KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 142 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $19,000 | +18.8% | 2,700 | 0.0% | 0.00% | – |
| Q1 2017 | $16,000 | -20.0% | 2,700 | -22.9% | 0.00% | – |
| Q4 2016 | $20,000 | +11.1% | 3,500 | 0.0% | 0.00% | – |
| Q3 2016 | $18,000 | -21.7% | 3,500 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $23,000 | -23.3% | 3,500 | -46.2% | 0.00% | 0.0% |
| Q1 2016 | $30,000 | +42.9% | 6,500 | +51.2% | 0.00% | 0.0% |
| Q4 2015 | $21,000 | +40.0% | 4,300 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $15,000 | -70.6% | 4,300 | -17.1% | 0.00% | -50.0% |
| Q2 2015 | $51,000 | -1.9% | 5,186 | +25.0% | 0.00% | 0.0% |
| Q1 2015 | $52,000 | -5.5% | 4,149 | +5.1% | 0.00% | 0.0% |
| Q4 2014 | $55,000 | +66.7% | 3,949 | +61.2% | 0.00% | +100.0% |
| Q3 2014 | $33,000 | +10.0% | 2,449 | +22.4% | 0.00% | 0.0% |
| Q2 2014 | $30,000 | -11.8% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $34,000 | +36.0% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $25,000 | +25.0% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $20,000 | +42.9% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $14,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |